Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eliane Furrer

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|February 5, 2013
Prediction of immunisation performanceCelina M Hanson, Eliane Furrer, Nina Schwalbe, et al.
Bulletin of the World Health Organization|January 25, 2012
Advance market commitment for pneumococcal vaccines: putting theory into practiceTania Cernuschi, Eliane Furrer, Nina Schwalbe, et al.
Vaccine|September 15, 2015
Intellectual property rights and challenges for development of affordable human papillomavirus, rotavirus and pneumococcal vaccines: Patent landscaping and perspectives of developing country vaccine manufacturersSubhashini Chandrasekharan, Tahir Amin, Joyce Kim, et al.
Malaria Journal|April 26, 2026
Assessing safety in the RTS,S/AS01 malaria vaccine implementation programme: an overview and comparison of methodsDavid Schellenberg, Mary Hamel, Patricia Njuguna, et al.
Malaria Journal|June 16, 2026
The Malaria Vaccine Implementation Programme reduced clinical malaria in Kenya, 2020 to 2022 : Impact evaluation with predictive time-series models of routine surveillance dataJohn A Painter, Erika Wallender, Andrew N Hill, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|February 5, 2013
Prediction of immunisation performanceCelina M Hanson, Eliane Furrer, Nina Schwalbe, et al.
Bulletin of the World Health Organization|January 25, 2012
Advance market commitment for pneumococcal vaccines: putting theory into practiceTania Cernuschi, Eliane Furrer, Nina Schwalbe, et al.
Vaccine|September 15, 2015
Intellectual property rights and challenges for development of affordable human papillomavirus, rotavirus and pneumococcal vaccines: Patent landscaping and perspectives of developing country vaccine manufacturersSubhashini Chandrasekharan, Tahir Amin, Joyce Kim, et al.
Malaria Journal|April 26, 2026
Assessing safety in the RTS,S/AS01 malaria vaccine implementation programme: an overview and comparison of methodsDavid Schellenberg, Mary Hamel, Patricia Njuguna, et al.
Malaria Journal|June 16, 2026
The Malaria Vaccine Implementation Programme reduced clinical malaria in Kenya, 2020 to 2022 : Impact evaluation with predictive time-series models of routine surveillance dataJohn A Painter, Erika Wallender, Andrew N Hill, et al.
Pageof 1